Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RTS,S/AS01 vaccine (Mosquirix™): an overview
Matthew B. Laurens
Human Vaccines & Immunotherapeutics (2019) Vol. 16, Iss. 3, pp. 480-489
Open Access | Times Cited: 370

Showing 1-25 of 370 citing articles:

Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action
Carlo Pifferi, Roberto González Fuentes, Alberto Fernández‐Tejada
Nature Reviews Chemistry (2021) Vol. 5, Iss. 3, pp. 197-216
Open Access | Times Cited: 181
Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments
Sachin S. Shivatare, Vidya S. Shivatare, Chi‐Huey Wong
Chemical Reviews (2022) Vol. 122, Iss. 20, pp. 15603-15671
Open Access | Times Cited: 107
Emerging vaccine nanotechnology: From defense against infection to sniping cancer
Chan Feng, Yongjiang Li, Bijan Emiliano Ferdows, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 5, pp. 2206-2223
Open Access | Times Cited: 89
Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
Jingxing Yang, Jen‐Chih Tseng, Guann‐Yi Yu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 423-423
Open Access | Times Cited: 81
Platforms, advances, and technical challenges in virus-like particles-based vaccines
Reeshu Gupta, Kajal Arora, Sourav Singha Roy, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 62
Malaria vaccines: the 60-year journey of hope and final success—lessons learned and future prospects
Amal A. El‐Moamly, Mohamed Aly El-Sweify
Tropical Medicine and Health (2023) Vol. 51, Iss. 1
Open Access | Times Cited: 46
Malaria vaccines: a new era of prevention and control
Patrick E. Duffy, J. Patrick Gorres, Sara A. Healy, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 12, pp. 756-772
Closed Access | Times Cited: 19
Microfluidic systems for infectious disease diagnostics
Thomas Lehnert, Martin A. M. Gijs
Lab on a Chip (2024) Vol. 24, Iss. 5, pp. 1441-1493
Open Access | Times Cited: 16
Rational formulation and industrial manufacturing of lipid-based complex injectables: Landmarks and trends
Mariana Biscaia-Caleiras, Nuno A. Fonseca, Ana Sofia Lourenço, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 617-639
Closed Access | Times Cited: 15
Engineering Self-Assembling Protein Nanoparticles for Therapeutic Delivery
Audrey Olshefsky, Christian Richardson, Suzie H. Pun, et al.
Bioconjugate Chemistry (2022) Vol. 33, Iss. 11, pp. 2018-2034
Open Access | Times Cited: 53
Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
Aroosa Younis Nadeem, Adeeb Shehzad, Salman Ul Islam, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 713-713
Open Access | Times Cited: 48
Malaria diagnostic methods with the elimination goal in view
Olukunle O. Oyegoke, Leah Maharaj, Oluwasegun P. Akoniyon, et al.
Parasitology Research (2022) Vol. 121, Iss. 7, pp. 1867-1885
Open Access | Times Cited: 44
The Road to Elimination: Current State of Schistosomiasis Research and Progress Towards the End Game
Paul Ogongo, Ruth Nyakundi, Gerald K. Chege, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 42
Gene drive mosquitoes can aid malaria elimination by retarding Plasmodium sporogonic development
Astrid Hoermann, Tibebu Habtewold, Prashanth Selvaraj, et al.
Science Advances (2022) Vol. 8, Iss. 38
Open Access | Times Cited: 39
mRNA vaccine against malaria tailored for liver-resident memory T cells
Mitch Ganley, Lauren E. Holz, Jordan J. Minnell, et al.
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1487-1498
Closed Access | Times Cited: 36
Host-parasite interactions during Plasmodium infection: Implications for immunotherapies
Pankaj Chandley, Ravikant Ranjan, Sudhir Kumar, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 24
Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
Hassan Mumtaz, Abdullah Nadeem, Wajeeha Bilal, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 24
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections
Hong You, Malcolm K. Jones, Catherine A. Gordon, et al.
Clinical Microbiology Reviews (2023) Vol. 36, Iss. 1
Open Access | Times Cited: 22
Epidemiology and Current Trends in Malaria
Priya Patel, Arti A. Bagada, Nasir Vadia
(2024), pp. 261-282
Closed Access | Times Cited: 11
Vaccine adjuvants: current status, research and development, licensing, and future opportunities
Ying Cui, Megan Ho, Yongjie Hu, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 17, pp. 4118-4137
Open Access | Times Cited: 10
Vector-Borne/Zoonotic Diseases
James Shaw
(2024), pp. 65-100
Closed Access | Times Cited: 10
Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross-stage recognition of glutamate-rich repeats
Axelle Amen, Randy Yoo, Amanda Fabra-García, et al.
eLife (2025) Vol. 13
Open Access | Times Cited: 1
Targeting Bottlenecks in Malaria Transmission: Antibody‐Epitope Descriptions Guide the Design of Next‐Generation Biomedical Interventions
Randy Yoo, Matthijs M. Jore, Jean‐Philippe Julien
Immunological Reviews (2025) Vol. 330, Iss. 1
Open Access | Times Cited: 1
Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors
Carolyn M. Nielsen, Ane Ogbe, Isabela Pedroza‐Pacheco, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 3, pp. 100207-100207
Open Access | Times Cited: 44
mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
Clifford T. H. Hayashi, Yi Cao, Leor C. Clark, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top